MedPageToday -- BOSTON -- Rates of recurrent Clostridium difficile infection were slashed when patients were treated with the investigational drug fidaxomicin compared with vancomycin, researchers said here.
MedPageToday -- BOSTON -- Rates of recurrent Clostridium difficile infection were slashed when patients were treated with the investigational drug fidaxomicin compared with vancomycin, researchers said here.